Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris
Clinical trial NCT02959970 · COMPLETED
Trial details
- NCT number
- NCT02959970
- Sponsor
- Almirall, S.A.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-31
- Primary completion
- 2018-03-09
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.